VEGFA and colorectal cancer: Successful anti-VEGF therapies include bevacizumab, which has been approved for the treatment of colorectal cancer in combination with chemotherapy [21], and sorafenib, a VEGF receptor tyrosine kinase inhibitor approved for metastatic renal cell carcinoma [2].